BI
Biora Therapeutics, Inc.
BIORQ · OTC
$0.22 +0.00% (+$0.00)
Piotroski F-Score Moderate
4/9Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 5.31x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIORQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Aditya Mohanty
Employees
58
Headquarters
San Diego
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report